Carregant...
Those Who Pay Have a Say: A View on Oncology Drug Pricing and Reimbursement
Four recommendations are made to address the high costs of cancer therapy: remove coverage mandates from state and federal insurance law, create performance transparency for drug regimens, cap profit margins for administering drugs, and place every patient with a genetic mutation in a clinical trial...
Guardat en:
| Publicat a: | Oncologist |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AlphaMed Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943395/ https://ncbi.nlm.nih.gov/pubmed/27325749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2016-0119 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|